We are live on ! Find out more
VCNX

Vaccinex, Inc. Common Stock
VCNX

Delisted

VCNX was delisted on the 17th of December, 2024.

Back to rankings

11 hedge funds and large institutions have $7.21M invested in Vaccinex, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

8% less funds holding

Funds holding: 12 → 11 (-1)

33% less capital invested

Capital invested by funds: $10.7M → $7.21M (-$3.49M)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
11
Holders Change
-1
Holders Change %
-8.33%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
3
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$13.5K
2
Morgan Stanley
Morgan Stanley
New York
+$1.13K
3
OC
Oppenheimer & Co
New York
+$1.13K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.13K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$48.5K
2
Victory Capital Management
Victory Capital Management
Texas
-$3K
3
UBS Group
UBS Group
Switzerland
-$1.13K
4
PAM
Panagora Asset Management
Massachusetts
-$1K

VCNX Hedge Fund Activity: Q4 2019 in Review

11 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Vaccinex, Inc. Common Stock (VCNX) for Q4 2019, worth a combined $7.21M — down 33% from $10.7M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of VCNX and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 3 added.

The largest buyer was BlackRock, adding an estimated $13.5K. The largest seller was Millennium Management, cutting an estimated $48.5K.

  • 11 institutional investors held Vaccinex, Inc. Common Stock (VCNX) as of Q4 2019, down from 12 in Q3 2019.
  • Funds reported $7.21M of Vaccinex, Inc. Common Stock stock for Q4 2019, down 33% quarter-over-quarter.
  • 1 fund opened new Vaccinex, Inc. Common Stock positions in Q4 2019 and 2 closed out, a net change of -1 holder.
  • The largest Vaccinex, Inc. Common Stock buyer in Q4 2019 was BlackRock, an estimated $13.5K added.
  • The largest Vaccinex, Inc. Common Stock seller in Q4 2019 was Millennium Management, an estimated $48.5K sold.

Based on aggregated 13F filings for Q4 2019.